Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Premixed Versus Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation: A Randomized Clinical Trial

NCT06570096 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06570096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Premixed Versus Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation: A Randomized Clinical Trial
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
August 24, 2024
Completion date
March 16, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula, bupivacaine, lidocaine, premixed, sequential, supraclavicular brachial plexus block